FRAZIER MANAGEMENT LLC
SEATTLE, WA · CIK 1032165 · 13F filing filed 2020-02-13
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityFRAZIER MANAGEMENT, L.L.C. (US)
- Others nearbySeattle, WA
As an employer
US visa salary filings
- Filings FY20251
- Median salary offered$125,000
- Middle half$125,000 – $125,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Associate, Investment AnalystSeattle, WA | 1 | $125,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.
$596.2m
reported value
20positions
91.5%in top 10
—no comparable previous quarter
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PHATHOM PHARMACEUTICALS INC PHAT | $226.8m38.04% | — |
| MIRUM PHARMACEUTICALS INC MIRM | $87.5m14.67% | — |
| KRYSTAL BIOTECH INC KRYS | $49.6m8.31% | — |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $48.5m8.13% | — |
| COLLEGIUM PHARMACEUTICAL INC COLL | $38.8m6.51% | — |
| ANAPTYSBIO INC ANAB | $37.6m6.31% | — |
| GRITSTONE BIO INC GRTS | $18.5m3.10% | — |
| TRANSLATE BIO INC COM | $17.8m2.98% | — |
| APTINYX INC COM | $10.9m1.83% | — |
| ALPINE IMMUNE SCIENCES INC NVLS | $9.9m1.66% | — |
| MILLENDO THERAPEUTICS INC COM | $9.4m1.58% | — |
| ALLENA PHARMACEUTICALS ALNA | $9.1m1.52% | — |
| ITERUM THERAPEUTICS PLC ITRMF | $6.9m1.16% | — |
| ENTASIS THERAPEUTICS HLDGS I COM | $6.7m1.13% | — |
| NABRIVA THERAPEUTICS PLC NBRV | $5.6m0.94% | — |
| CIDARA THERAPEUTICS INC COM | $5.0m0.85% | — |
| ADVERUM BIOTECHNOLOGIES INC COM | $3.1m0.52% | — |
| SIERRA ONCOLOGY INC SRRA | $2.8m0.47% | — |
| BELLICUM PHARMACEUTICALS INC COM | $1.4m0.23% | — |
| KEZAR LIFE SCIENCES INC COM | $363.0k0.06% | — |